Results 221 to 230 of about 62,474 (297)

Early optical coherence tomography biomarkers for tailored frequency of intravitreal aflibercept in neovascular age-related macular degeneration. [PDF]

Sci Rep
Lim G, Kim KT, Kim DY, Chae JB, Seo EJ.
europepmc   +1 more source

Preferences of Hospital Pharmacists for the Different Attributes of Intravitreal Treatments for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Spain: The SEEKING Study. [PDF]

Pharmacy (Basel)
Poveda JL, Arnáiz P, López S, Muñoz B, Fernández-Ferreiro A.   +4 more
europepmc   +1 more source

Systemic oxidative stress levels and their associations with the risk of neovascular age-related macular degeneration and treatment response. [PDF]

Int J Retina Vitreous
Abe M, Kunikata H, Aizawa N, Yasuda M, Nitta F, Abe T, Nakazawa T.   +6 more
europepmc   +1 more source

Refractory Neovascular Age-related Macular Degeneration

Journal of Retina, 2017
Dae Joong Ma, Hyeong Gon Yu
openaire   +3 more sources

Metformin inhibits pathological retinal neovascularization but promotes retinal fibrosis in experimental neovascular age-related macular degeneration. [PDF]

Front Pharmacol
Wang X, Liang X, Huang S, Wei M, Xu Y, Chen X, Miao Y, Zong R, Lin X, Li S, Liu Z, Chen Q.   +11 more
europepmc   +1 more source

Indications of the SERPINE 1 variant rs1799768's role in anti-VEGF therapy resistance in neovascular age-related macular degeneration. [PDF]

PLoS One
Çevik MÖ, Mert Altuntaş Z, Çevik SG.
europepmc   +1 more source

Two-Years Real-World Experience of a Tertiary Center with Intravitreal Brolucizumab Switch for Treatment of Exudative Neovascular Age-Related Macular Degeneration. [PDF]

Ophthalmol Ther
Beretta F, Zucchiatti I, Sacconi R, Fantaguzzi F, Lingardo S, Bandello F, Querques G.   +6 more
europepmc   +1 more source

Retinal sensitivity above macular neovascularization under anti-VEGF therapy in exudative neovascular age-related macular degeneration. [PDF]

BMC Ophthalmol
Pauleikhoff L, Ziegler M, Bachmeier I, Yu S, Armendariz BG, Pauleikhoff D.   +5 more
europepmc   +1 more source

The Impact of Disease Activity Criteria on Extending Injection Intervals in Real-World Patients with Neovascular Age-Related Macular Degeneration. [PDF]

Ophthalmol Ther
Bhatia B, Sim SY, Chalkiadaki E, Koutsocheras G, Nicholson L, Selvam S, Sivaprasad S, Pal B, Huemer J, Keane PA, Hamilton R, Patel PJ, Moorfields Medical Retina Injection Service.   +12 more
europepmc   +1 more source

Long-term macular atrophy growth in neovascular age-related macular degeneration: influential factors and role of genetic variants. [PDF]

Eye (Lond)
Vofo BN, Shwartz Y, Cnaany Y, Jaskoll S, Kramer A, Elbaz-Hayoun S, Rinsky B, Grunin M, Tiosano L, Chowers I.   +9 more
europepmc   +1 more source